{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "06",
                "@timestamp": "2021-07-06T03:54:07.000007-04:00",
                "@year": "2021",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2020",
                "@month": "08"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "AIL Milano e Provincia ONLUS"},
                {"xocs:funding-agency-matched-string": "Angiocrine Bioscience, Inc."},
                {"xocs:funding-agency-matched-string": "Janssen Pharmaceutical"},
                {"xocs:funding-agency-matched-string": "NIH/NCI"},
                {
                    "xocs:funding-agency-matched-string": "NIH",
                    "xocs:funding-agency-acronym": "NIH",
                    "xocs:funding-agency": "National Institutes of Health",
                    "xocs:funding-id": "P01 CA23766",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000002",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-acronym": "NCI",
                    "xocs:funding-agency": "National Cancer Institute",
                    "xocs:funding-id": "P30CA008748",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000054",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001"
                },
                {
                    "xocs:funding-agency-matched-string": "Amgen",
                    "xocs:funding-agency": "Amgen",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100002429",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Novartis",
                    "xocs:funding-agency": "Novartis",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004336",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2658434/"
                },
                {
                    "xocs:funding-agency-matched-string": "American Italian Cancer Foundation",
                    "xocs:funding-agency-acronym": "AICF",
                    "xocs:funding-agency": "American-Italian Cancer Foundation",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100005410",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2023-03-16T22:38:24.931218Z",
            "xocs:funding-text": [
                {"$": "This research was supported in part by NIH award P01 CA23766 and NIH/NCI Cancer Center Support Grant P30 CA008748. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. K.W. receives salary support from Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center. M.P. received salary support from an American Italian Cancer Foundation Post-Doctoral Research Fellowship and by AIL Milano e Provincia ONLUS."},
                {"$": "K.W., M.P., J.R.F., S.M.D., A.A., M.L.S., M.A.M., and S.K.S. have no relevant conflict of interest. M.G.R. reports receiving honoraria from Takeda and Janssen Pharmaceutical. M.S. has served as a paid consultant for McKinsey & Company, Angiocrine Bioscience, Inc., and Omeros Corporation. He has received research funding from Angiocrine Bioscience, Inc. He has served on an ad hoc advisory board for Kite\u2014A Gilead Company. G.L.S. receives research funding from Amgen and Janssen Pharmaceutical. C.L.B. serves as a paid consultant for Life Sci, GLG, Juno/Celgene, Seattle Genetics and Kite/Gilead. She reports receiving research funding from Janssen Pharmaceutical, Novartis, Epizyme, Xynomics and Bayer. She receives honorarium from Dava Oncology. M.L.P. has served on ad hoc advisory board for Kite and Novartis. P.B.D. serves on the advisory board for Kite/Gilead. C.S.S. has served as a paid consultant on advisory boards for Juno Therapeutics, Sanofi-Genzyme, Spectrum Pharmaceuticals, Novartis, Genmab, Precision Biosciences, Kite, a Gilead Company, Celgene, Gamida Cell and GSK. He has received research funds for clinical trials from Juno Therapeutics, Celgene, Precision Biosciences and Sanofi-Genzyme. B.D.S. provides consultancy for Kite/Gilead, Juno/Celgene and Janssen. She also receives research support from ADC Therapeutics. M.A.P. reports honoraria from Kite/Gilead, Abbvie, Bellicum, Bristol-Myers Squibb, Incyte, Merck, Novartis, Nektar Therapeutics, Omeros, and Takeda. He serves on DSMBs for Servier and Medigene, and the scientific advisory boards of MolMed and NexImmune. He has received research support for clinical trials from Incyte, Kite/Gilead and Miltenyi Biotec. He serves in a volunteer capacity as a member of the Board of Directors of the American Society for Transplantation and Cellular Therapy (ASTCT) and Be the Match (National Marrow Donor Program, NMDP), as well as on the CIBMTR Cellular Immunotherapy Data Resource (CIDR) Committee."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60009343",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Adult Bone Marrow Transplant Service"},
                                {"$": "Department of Medicine"},
                                {"$": "Memorial Sloan Kettering Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009343",
                                "@dptid": "109501192"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "2005775520-4bec1f9b80f438c921456c7599258d30",
                            "ce:source-text": "Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA",
                            "@dptid": "109501192"
                        },
                        "author": [
                            {
                                "ce:given-name": "Kitsada",
                                "preferred-name": {
                                    "ce:given-name": "Kitsada",
                                    "ce:initials": "K.",
                                    "ce:surname": "Wudhikarn",
                                    "ce:indexed-name": "Wudhikarn K."
                                },
                                "@author-instance-id": "2005775520-d7a25d8a02d7e8516a087bd5557b10ae",
                                "@seq": "1",
                                "ce:initials": "K.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Wudhikarn",
                                "@auid": "37091810400",
                                "@orcid": "0000-0001-9528-8681",
                                "ce:indexed-name": "Wudhikarn K."
                            },
                            {
                                "ce:given-name": "Martina",
                                "preferred-name": {
                                    "ce:given-name": "Martina",
                                    "ce:initials": "M.",
                                    "ce:surname": "Pennisi",
                                    "ce:indexed-name": "Pennisi M."
                                },
                                "@author-instance-id": "2005775520-d29c4061e27f704a6fc066dc6129aea8",
                                "@seq": "3",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Pennisi",
                                "@auid": "56325972600",
                                "ce:indexed-name": "Pennisi M."
                            },
                            {
                                "ce:given-name": "Marta",
                                "preferred-name": {
                                    "ce:given-name": "Marta",
                                    "ce:initials": "M.",
                                    "ce:surname": "Garcia-Recio",
                                    "ce:indexed-name": "Garcia-Recio M."
                                },
                                "@author-instance-id": "2005775520-fab6e1b396226c7bae9d61c02c2b4c4c",
                                "@seq": "4",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Garcia-Recio",
                                "@auid": "57189461287",
                                "ce:indexed-name": "Garcia-Recio M."
                            },
                            {
                                "ce:given-name": "Aishat",
                                "preferred-name": {
                                    "ce:given-name": "Aishat",
                                    "ce:initials": "A.",
                                    "ce:surname": "Afuye",
                                    "ce:indexed-name": "Afuye A."
                                },
                                "@author-instance-id": "2005775520-5a965685a97c70826baa663bf3986d1d",
                                "@seq": "7",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Afuye",
                                "@auid": "57218200707",
                                "@orcid": "0000-0002-5751-3283",
                                "ce:indexed-name": "Afuye A."
                            },
                            {
                                "ce:given-name": "Mari Lynne",
                                "preferred-name": {
                                    "ce:given-name": "Mari Lynne",
                                    "ce:initials": "M.L.",
                                    "ce:surname": "Silverberg",
                                    "ce:indexed-name": "Silverberg M.L."
                                },
                                "@author-instance-id": "2005775520-5cb8bfa7ad36037a203f8d1f6371cc2b",
                                "@seq": "8",
                                "ce:initials": "M.L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Silverberg",
                                "@auid": "57215874261",
                                "ce:indexed-name": "Silverberg M.L."
                            },
                            {
                                "ce:given-name": "Molly A.",
                                "preferred-name": {
                                    "ce:given-name": "Molly A.",
                                    "ce:initials": "M.A.",
                                    "ce:surname": "Maloy",
                                    "ce:indexed-name": "Maloy M.A."
                                },
                                "@author-instance-id": "2005775520-c30c7a10d3c8915b1b04bdec9071b8f0",
                                "@seq": "9",
                                "ce:initials": "M.A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Maloy",
                                "@auid": "55711016700",
                                "ce:indexed-name": "Maloy M.A."
                            },
                            {
                                "ce:given-name": "Gunjan L.",
                                "preferred-name": {
                                    "ce:given-name": "Gunjan L.",
                                    "ce:initials": "G.L.",
                                    "ce:surname": "Shah",
                                    "ce:indexed-name": "Shah G.L."
                                },
                                "@author-instance-id": "2005775520-4e3163d133af7c5b6933690fc092e1fd",
                                "@seq": "10",
                                "ce:initials": "G.L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Shah",
                                "@auid": "55628590808",
                                "ce:indexed-name": "Shah G.L."
                            },
                            {
                                "ce:given-name": "Michael",
                                "preferred-name": {
                                    "ce:given-name": "Michael",
                                    "ce:initials": "M.",
                                    "ce:surname": "Scordo",
                                    "ce:indexed-name": "Scordo M."
                                },
                                "@author-instance-id": "2005775520-8c8cfad1730b4e52d036d98dcba96304",
                                "@seq": "11",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Scordo",
                                "@auid": "36193395200",
                                "ce:indexed-name": "Scordo M."
                            },
                            {
                                "ce:given-name": "Parastoo B.",
                                "preferred-name": {
                                    "ce:given-name": "Parastoo B.",
                                    "ce:initials": "P.B.",
                                    "ce:surname": "Dahi",
                                    "ce:indexed-name": "Dahi P.B."
                                },
                                "@author-instance-id": "2005775520-961567cb83fbdacf0bb9944bd8fbc0bb",
                                "@seq": "12",
                                "ce:initials": "P.B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Dahi",
                                "@auid": "56015514000",
                                "@orcid": "0000-0002-0794-3226",
                                "ce:indexed-name": "Dahi P.B."
                            },
                            {
                                "ce:given-name": "Craig S.",
                                "preferred-name": {
                                    "ce:given-name": "Craig S.",
                                    "ce:initials": "C.S.",
                                    "ce:surname": "Sauter",
                                    "ce:indexed-name": "Sauter C.S."
                                },
                                "@author-instance-id": "2005775520-0c275fcfad1430ab6efd2140040699f8",
                                "@seq": "13",
                                "ce:initials": "C.S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sauter",
                                "@auid": "25028670000",
                                "ce:indexed-name": "Sauter C.S."
                            },
                            {
                                "ce:given-name": "Miguel-Angel",
                                "preferred-name": {
                                    "ce:given-name": "Miguel Angel",
                                    "ce:initials": "M.A.",
                                    "ce:surname": "Perales",
                                    "ce:indexed-name": "Perales M.A."
                                },
                                "@author-instance-id": "2005775520-43be8b53b05f2790ac7a80c10a5a6c75",
                                "@seq": "18",
                                "ce:initials": "M.-A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Perales",
                                "@auid": "6701893624",
                                "@orcid": "0000-0002-5910-4571",
                                "ce:indexed-name": "Perales M.-A."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Hematology and Research Unit in Translational Hematology"},
                                {"$": "Department of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113019942"
                            },
                            "@affiliation-instance-id": "2005775520-88a15aabb64d7b9bcfb1f8e1837f6cf3",
                            "ce:source-text": "Division of Hematology and Research Unit in Translational Hematology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "113019942"
                        },
                        "author": [{
                            "ce:given-name": "Kitsada",
                            "preferred-name": {
                                "ce:given-name": "Kitsada",
                                "ce:initials": "K.",
                                "ce:surname": "Wudhikarn",
                                "ce:indexed-name": "Wudhikarn K."
                            },
                            "@author-instance-id": "2005775520-d7a25d8a02d7e8516a087bd5557b10ae",
                            "@seq": "1",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Wudhikarn",
                            "@auid": "37091810400",
                            "ce:indexed-name": "Wudhikarn K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60009343",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Lymphoma Service"},
                                {"$": "Department of Medicine"},
                                {"$": "Memorial Sloan Kettering Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009343",
                                "@dptid": "109501192"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "2005775520-9fb56ee6f49b44633b9220c8cf3e8330",
                            "ce:source-text": "Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA",
                            "@dptid": "109501192"
                        },
                        "author": [
                            {
                                "ce:given-name": "M. Lia",
                                "preferred-name": {
                                    "ce:given-name": "M. Lia",
                                    "ce:initials": "M.L.",
                                    "ce:surname": "Palomba",
                                    "ce:indexed-name": "Palomba M.L."
                                },
                                "@author-instance-id": "2005775520-7be944c9610fd4f4a7905f9894cabeb6",
                                "@seq": "2",
                                "ce:initials": "M.L.",
                                "@date-locked": "2020-09-29T07:51:26.567",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Palomba",
                                "@auid": "7004154707",
                                "@orcid": "0000-0001-5099-9156",
                                "ce:indexed-name": "Palomba M.L."
                            },
                            {
                                "ce:given-name": "Connie L.",
                                "preferred-name": {
                                    "ce:given-name": "Connie L.",
                                    "ce:initials": "C.L.",
                                    "ce:surname": "Batlevi",
                                    "ce:indexed-name": "Batlevi C.L."
                                },
                                "@author-instance-id": "2005775520-5bbb1135c200d8945c702e2e389c3ed0",
                                "@seq": "14",
                                "ce:initials": "C.L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Batlevi",
                                "@auid": "56131589300",
                                "@orcid": "0000-0002-9036-9463",
                                "ce:indexed-name": "Batlevi C.L."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60007997",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Weill Cornell Medical College"}
                            ],
                            "affiliation-id": {
                                "@afid": "60007997",
                                "@dptid": "112748380"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "2005775520-a036894edd79c67df6ded21f942b29f9",
                            "ce:source-text": "Department of Medicine, Weill Cornell Medical College, New York, NY, USA",
                            "@dptid": "112748380"
                        },
                        "author": [
                            {
                                "ce:given-name": "M. Lia",
                                "preferred-name": {
                                    "ce:given-name": "M. Lia",
                                    "ce:initials": "M.L.",
                                    "ce:surname": "Palomba",
                                    "ce:indexed-name": "Palomba M.L."
                                },
                                "@author-instance-id": "2005775520-7be944c9610fd4f4a7905f9894cabeb6",
                                "@seq": "2",
                                "ce:initials": "M.L.",
                                "@date-locked": "2020-09-29T07:51:26.567",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Palomba",
                                "@auid": "7004154707",
                                "ce:indexed-name": "Palomba M.L."
                            },
                            {
                                "ce:given-name": "Gunjan L.",
                                "preferred-name": {
                                    "ce:given-name": "Gunjan L.",
                                    "ce:initials": "G.L.",
                                    "ce:surname": "Shah",
                                    "ce:indexed-name": "Shah G.L."
                                },
                                "@author-instance-id": "2005775520-4e3163d133af7c5b6933690fc092e1fd",
                                "@seq": "10",
                                "ce:initials": "G.L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Shah",
                                "@auid": "55628590808",
                                "ce:indexed-name": "Shah G.L."
                            },
                            {
                                "ce:given-name": "Michael",
                                "preferred-name": {
                                    "ce:given-name": "Michael",
                                    "ce:initials": "M.",
                                    "ce:surname": "Scordo",
                                    "ce:indexed-name": "Scordo M."
                                },
                                "@author-instance-id": "2005775520-8c8cfad1730b4e52d036d98dcba96304",
                                "@seq": "11",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Scordo",
                                "@auid": "36193395200",
                                "ce:indexed-name": "Scordo M."
                            },
                            {
                                "ce:given-name": "Parastoo B.",
                                "preferred-name": {
                                    "ce:given-name": "Parastoo B.",
                                    "ce:initials": "P.B.",
                                    "ce:surname": "Dahi",
                                    "ce:indexed-name": "Dahi P.B."
                                },
                                "@author-instance-id": "2005775520-961567cb83fbdacf0bb9944bd8fbc0bb",
                                "@seq": "12",
                                "ce:initials": "P.B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Dahi",
                                "@auid": "56015514000",
                                "ce:indexed-name": "Dahi P.B."
                            },
                            {
                                "ce:given-name": "Craig S.",
                                "preferred-name": {
                                    "ce:given-name": "Craig S.",
                                    "ce:initials": "C.S.",
                                    "ce:surname": "Sauter",
                                    "ce:indexed-name": "Sauter C.S."
                                },
                                "@author-instance-id": "2005775520-0c275fcfad1430ab6efd2140040699f8",
                                "@seq": "13",
                                "ce:initials": "C.S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sauter",
                                "@auid": "25028670000",
                                "ce:indexed-name": "Sauter C.S."
                            },
                            {
                                "ce:given-name": "Connie L.",
                                "preferred-name": {
                                    "ce:given-name": "Connie L.",
                                    "ce:initials": "C.L.",
                                    "ce:surname": "Batlevi",
                                    "ce:indexed-name": "Batlevi C.L."
                                },
                                "@author-instance-id": "2005775520-5bbb1135c200d8945c702e2e389c3ed0",
                                "@seq": "14",
                                "ce:initials": "C.L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Batlevi",
                                "@auid": "56131589300",
                                "ce:indexed-name": "Batlevi C.L."
                            },
                            {
                                "ce:given-name": "Bianca D.",
                                "preferred-name": {
                                    "ce:given-name": "Bianca D.",
                                    "ce:initials": "B.D.",
                                    "ce:surname": "Santomasso",
                                    "ce:indexed-name": "Santomasso B.D."
                                },
                                "@author-instance-id": "2005775520-349be84f27fcbb17f0398ae6a2bf1b3f",
                                "@seq": "15",
                                "ce:initials": "B.D.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Santomasso",
                                "@auid": "23104363800",
                                "ce:indexed-name": "Santomasso B.D."
                            },
                            {
                                "ce:given-name": "Elena",
                                "preferred-name": {
                                    "ce:given-name": "Elena",
                                    "ce:initials": "E.",
                                    "ce:surname": "Mead",
                                    "ce:indexed-name": "Mead E."
                                },
                                "@author-instance-id": "2005775520-d0ba98badd41bafc66f94b620b8fbc62",
                                "@seq": "16",
                                "ce:initials": "E.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Mead",
                                "@auid": "57189727938",
                                "ce:indexed-name": "Mead E."
                            },
                            {
                                "ce:given-name": "Susan K.",
                                "preferred-name": {
                                    "ce:given-name": "Susan K.",
                                    "ce:initials": "S.K.",
                                    "ce:surname": "Seo",
                                    "ce:indexed-name": "Seo S.K."
                                },
                                "@author-instance-id": "2005775520-59a73b9ee48c280ae6ec5d3c8b61f3be",
                                "@seq": "17",
                                "ce:initials": "S.K.",
                                "@date-locked": "2020-10-20T12:18:26.953",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Seo",
                                "@auid": "7202469856",
                                "ce:indexed-name": "Seo S.K."
                            },
                            {
                                "ce:given-name": "Miguel-Angel",
                                "preferred-name": {
                                    "ce:given-name": "Miguel Angel",
                                    "ce:initials": "M.A.",
                                    "ce:surname": "Perales",
                                    "ce:indexed-name": "Perales M.A."
                                },
                                "@author-instance-id": "2005775520-43be8b53b05f2790ac7a80c10a5a6c75",
                                "@seq": "18",
                                "ce:initials": "M.-A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Perales",
                                "@auid": "6701893624",
                                "ce:indexed-name": "Perales M.-A."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Italy",
                            "@afid": "60006583",
                            "@country": "ita",
                            "city": "Milan",
                            "organization": [
                                {"$": "Division of Hematology"},
                                {"$": "Oncology and Hemato-Oncology Department"},
                                {"$": "Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60006583",
                                    "@dptid": "117644619"
                                },
                                {"@afid": "60030318"}
                            ],
                            "@affiliation-instance-id": "2005775520-1cc31a1e555884a777a6ed9215bbd21e",
                            "ce:source-text": "Division of Hematology, Oncology and Hemato-Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy",
                            "@dptid": "117644619"
                        },
                        "author": [{
                            "ce:given-name": "Martina",
                            "preferred-name": {
                                "ce:given-name": "Martina",
                                "ce:initials": "M.",
                                "ce:surname": "Pennisi",
                                "ce:indexed-name": "Pennisi M."
                            },
                            "@author-instance-id": "2005775520-d29c4061e27f704a6fc066dc6129aea8",
                            "@seq": "3",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Pennisi",
                            "@auid": "56325972600",
                            "ce:indexed-name": "Pennisi M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60009343",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Department of Biostatistics and Epidemiology"},
                                {"$": "Memorial Sloan Kettering Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009343",
                                "@dptid": "113531958"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "2005775520-05dd43d9ad06909dd61cab41906d5ba6",
                            "ce:source-text": "Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA",
                            "@dptid": "113531958"
                        },
                        "author": [
                            {
                                "ce:given-name": "Jessica R.",
                                "preferred-name": {
                                    "ce:given-name": "Jessica R.",
                                    "ce:initials": "J.R.",
                                    "ce:surname": "Flynn",
                                    "ce:indexed-name": "Flynn J.R."
                                },
                                "@author-instance-id": "2005775520-0f2d5c062ed0fa6021cda1bb5f94f1d0",
                                "@seq": "5",
                                "ce:initials": "J.R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Flynn",
                                "@auid": "57203165820",
                                "ce:indexed-name": "Flynn J.R."
                            },
                            {
                                "ce:given-name": "Sean M.",
                                "preferred-name": {
                                    "ce:given-name": "Sean M.",
                                    "ce:initials": "S.M.",
                                    "ce:surname": "Devlin",
                                    "ce:indexed-name": "Devlin S.M."
                                },
                                "@author-instance-id": "2005775520-9213be00b08ffe3f87b05610814697a6",
                                "@seq": "6",
                                "ce:initials": "S.M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Devlin",
                                "@auid": "55515156100",
                                "ce:indexed-name": "Devlin S.M."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60009343",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Department of Neurology"},
                                {"$": "Memorial Sloan Kettering Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009343",
                                "@dptid": "112759803"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "2005775520-64de6df770a49d36bda06283f0c5d3bb",
                            "ce:source-text": "Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA",
                            "@dptid": "112759803"
                        },
                        "author": [{
                            "ce:given-name": "Bianca D.",
                            "preferred-name": {
                                "ce:given-name": "Bianca D.",
                                "ce:initials": "B.D.",
                                "ce:surname": "Santomasso",
                                "ce:indexed-name": "Santomasso B.D."
                            },
                            "@author-instance-id": "2005775520-349be84f27fcbb17f0398ae6a2bf1b3f",
                            "@seq": "15",
                            "ce:initials": "B.D.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Santomasso",
                            "@auid": "23104363800",
                            "ce:indexed-name": "Santomasso B.D."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60009343",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Critical Care Medicine Service"},
                                {"$": "Department of Anesthesiology and Critical Care Medicine"},
                                {"$": "Memorial Sloan Kettering Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009343",
                                "@dptid": "113904545"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "2005775520-1ba3cb40a384d6ea68e43975f11009e6",
                            "ce:source-text": "Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA",
                            "@dptid": "113904545"
                        },
                        "author": [{
                            "ce:given-name": "Elena",
                            "preferred-name": {
                                "ce:given-name": "Elena",
                                "ce:initials": "E.",
                                "ce:surname": "Mead",
                                "ce:indexed-name": "Mead E."
                            },
                            "@author-instance-id": "2005775520-d0ba98badd41bafc66f94b620b8fbc62",
                            "@seq": "16",
                            "ce:initials": "E.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Mead",
                            "@auid": "57189727938",
                            "ce:indexed-name": "Mead E."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60009343",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Infectious Disease Service"},
                                {"$": "Department of Medicine"},
                                {"$": "Memorial Sloan Kettering Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009343",
                                "@dptid": "109501192"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "2005775520-173173dd47ba5d0f2d2793df9d5f2605",
                            "ce:source-text": "Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA",
                            "@dptid": "109501192"
                        },
                        "author": [{
                            "ce:given-name": "Susan K.",
                            "preferred-name": {
                                "ce:given-name": "Susan K.",
                                "ce:initials": "S.K.",
                                "ce:surname": "Seo",
                                "ce:indexed-name": "Seo S.K."
                            },
                            "@author-instance-id": "2005775520-59a73b9ee48c280ae6ec5d3c8b61f3be",
                            "@seq": "17",
                            "ce:initials": "S.K.",
                            "@date-locked": "2020-10-20T12:18:26.953",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Seo",
                            "@auid": "7202469856",
                            "ce:indexed-name": "Seo S.K."
                        }]
                    }
                ],
                "citation-title": "Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma",
                "abstracts": "© 2020, The Author(s).CD19-targeted chimeric antigen receptor (CAR) T cell therapy is an effective treatment for diffuse large B cell lymphoma (DLBCL). In addition to cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity (ICANS), B cell aplasia and hypogammaglobulinemia are common toxicities predisposing these patients to infections. We analyzed 60 patients with DLBCL treated with FDA-approved CD19 CAR T cells and report the incidence, risk factors, and management of infections during the first year after treatment. A total of 101 infectious events were observed, including 25 mild, 51 moderate, 23 severe, 1 life-threatening, and 1 fatal infection. Bacteria were the most common causative pathogens. The cumulative incidence of overall, bacterial, severe bacterial, viral, and fungal infection at 1 year were 63.3%, 57.2%, 29.6%, 44.7%, and 4%, respectively. In multivariate analyses, the use of systemic corticosteroids for the management of CRS or ICANS was associated with an increased risk of infections and prolonged admission. Impaired performance status and history of infections within 30 days before CAR T cell therapy was a risk factor for severe bacterial infection. In conclusion, infections were common within the first 60 days after CAR T cell therapy, however, they were not associated with an increased risk of death.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "@country": "usa",
                        "city": "New York",
                        "organization": [
                            {"$": "Adult Bone Marrow Transplant Service"},
                            {"$": "Department of Medicine"},
                            {"$": "Memorial Sloan Kettering Cancer Center"}
                        ],
                        "state": "NY",
                        "ce:source-text": "Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA"
                    },
                    "person": {
                        "ce:given-name": "Miguel-Angel",
                        "ce:initials": "M.-A.",
                        "ce:surname": "Perales",
                        "ce:indexed-name": "Perales M.-A."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://www.nature.com/bcj/index.html",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Blood Cancer Journal",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {"voliss": {
                        "@volume": "10",
                        "@issue": "8"
                    }},
                    "@type": "j",
                    "sourcetitle": "Blood Cancer Journal",
                    "publicationdate": {
                        "month": "08",
                        "year": "2020",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 August 2020"
                        },
                        "day": "01"
                    },
                    "sourcetitle-abbrev": "Blood Cancer J.",
                    "@country": "gbr",
                    "issn": {
                        "$": "20445385",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2020"},
                    "publisher": {"publishername": "Springer Nature"},
                    "article-number": "79",
                    "@srcid": "21100205926"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "25",
                                    "classification-description": "Hematology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2720"},
                                {"$": "2730"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "tradenamegroup": {"tradenames": {
                        "trademanuitem": [
                            {
                                "tradename": "kymriah",
                                "manufacturer": {
                                    "@country": "che",
                                    "$": "Novartis"
                                }
                            },
                            {
                                "tradename": "yescarta",
                                "manufacturer": {
                                    "@country": "usa",
                                    "$": "Kite"
                                }
                            }
                        ],
                        "@type": "TNM"
                    }},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "59277-89-3",
                                    "chemical-name": "aciclovir"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "16506-27-7"},
                                        {"$": "3543-75-7"}
                                    ],
                                    "chemical-name": "bendamustine"
                                },
                                {
                                    "cas-registry-number": "8064-90-2",
                                    "chemical-name": "cotrimoxazole"
                                },
                                {
                                    "cas-registry-number": "50-18-0",
                                    "chemical-name": "cyclophosphamide"
                                },
                                {
                                    "cas-registry-number": "86386-73-4",
                                    "chemical-name": "fluconazole"
                                },
                                {
                                    "cas-registry-number": "21679-14-1",
                                    "chemical-name": "fludarabine"
                                },
                                {
                                    "cas-registry-number": "103882-84-4",
                                    "chemical-name": "gemcitabine"
                                },
                                {
                                    "cas-registry-number": "100-33-4",
                                    "chemical-name": "pentamidine"
                                },
                                {
                                    "cas-registry-number": "174722-31-7",
                                    "chemical-name": "rituximab"
                                },
                                {
                                    "cas-registry-number": "137234-62-9",
                                    "chemical-name": "voriconazole"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Anti-Infective Agents"},
                                {"chemical-name": "Antigens, CD19"}
                            ]
                        }
                    ]},
                    "manufacturergroup": {"manufacturers": {
                        "@type": "MNF",
                        "manufacturer": [
                            {
                                "@country": "che",
                                "$": "Novartis"
                            },
                            {
                                "@country": "usa",
                                "$": "Kite"
                            }
                        ]
                    }}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant": {
                        "grant-id": "P30 CA008748",
                        "grant-acronym": "NCI",
                        "grant-agency": {
                            "@iso-code": "usa",
                            "$": "National Cancer Institute"
                        },
                        "grant-agency-id": "100000054"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2020 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Data-Review",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "18",
                    "@timestamp": "BST 03:46:11",
                    "@year": "2020",
                    "@month": "08"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2005775520",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "927480919",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20200650838",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "32759935",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20201678389",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2020284399",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20202847434",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2020001237421X",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85089023617",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85089023617",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "632549683",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "301969399",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1038/s41408-020-00346-7"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "34",
                "reference": [
                    {
                        "ref-fulltext": "Yanez, L., Sanchez-Escamilla, M. & Perales, M. A. CAR T cell toxicity: current management and future directions. Hemasphere. 3, e186 (2019). DOI: 10.1097/HS9.0000000000000186",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "CAR T cell toxicity: current management and future directions"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/HS9.0000000000000186",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e186",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85072527563",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "3"}},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Yanez",
                                    "ce:indexed-name": "Yanez L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Sanchez-Escamilla",
                                    "ce:indexed-name": "Sanchez-Escamilla M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Perales",
                                    "ce:indexed-name": "Perales M.A."
                                }
                            ]},
                            "ref-sourcetitle": "Hemasphere."
                        },
                        "ce:source-text": "Yanez, L., Sanchez-Escamilla, M. & Perales, M. A. CAR T cell toxicity: current management and future directions. Hemasphere. 3, e186 (2019). DOI: 10.1097/HS9.0000000000000186"
                    },
                    {
                        "ref-fulltext": "Jain, T. et al. Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the american society for transplantation and cellular therapy. Biol Blood Marrow Transplant. 25, 2305\u20132321 (2019). DOI: 10.1016/j.bbmt.2019.08.015",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the american society for transplantation and cellular therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.bbmt.2019.08.015",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85072519127",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "2305",
                                    "@last": "2321"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC1MXhvVWisr7P",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Jain",
                                    "ce:indexed-name": "Jain T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biol Blood Marrow Transplant."
                        },
                        "ce:source-text": "Jain, T. et al. Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the american society for transplantation and cellular therapy. Biol Blood Marrow Transplant. 25, 2305\u20132321 (2019). DOI: 10.1016/j.bbmt.2019.08.015"
                    },
                    {
                        "ref-fulltext": "Nahas, G. et al. Persistent cytopenias after chimeric antigen receptor T-cell immunotherapy for CD19+ aggressive lymphoma: a single institution experience. Biol. Blood Marrow Transplant. 25, S180 (2019). DOI: 10.1016/j.bbmt.2018.12.324",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Persistent cytopenias after chimeric antigen receptor T-cell immunotherapy for CD19+ aggressive lymphoma: a single institution experience"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.bbmt.2018.12.324",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85078657021",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {"@first": "S180"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Nahas",
                                    "ce:indexed-name": "Nahas G."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biol. Blood Marrow Transplant."
                        },
                        "ce:source-text": "Nahas, G. et al. Persistent cytopenias after chimeric antigen receptor T-cell immunotherapy for CD19+ aggressive lymphoma: a single institution experience. Biol. Blood Marrow Transplant. 25, S180 (2019). DOI: 10.1016/j.bbmt.2018.12.324"
                    },
                    {
                        "ref-fulltext": "Fried, S. et al. Early and late hematologic toxicity following CD19 CAR-T cells. Bone Marrow Transplant. 54, 1643\u20131650 (2019). DOI: 10.1038/s41409-019-0487-3",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Early and late hematologic toxicity following CD19 CAR-T cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s41409-019-0487-3",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85062147434",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "54"},
                                "pagerange": {
                                    "@first": "1643",
                                    "@last": "1650"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC1MXhtFWntrfM",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Fried",
                                    "ce:indexed-name": "Fried S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Bone Marrow Transplant."
                        },
                        "ce:source-text": "Fried, S. et al. Early and late hematologic toxicity following CD19 CAR-T cells. Bone Marrow Transplant. 54, 1643\u20131650 (2019). DOI: 10.1038/s41409-019-0487-3"
                    },
                    {
                        "ref-fulltext": "Hill, J. A. et al. Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy. Blood. 131, 121\u2013130 (2018). DOI: 10.1182/blood-2017-07-793760",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2017-07-793760",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85040089946",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "131"},
                                "pagerange": {
                                    "@first": "121",
                                    "@last": "130"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC1cXhs1Cru7nK",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Hill",
                                    "ce:indexed-name": "Hill J.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood."
                        },
                        "ce:source-text": "Hill, J. A. et al. Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy. Blood. 131, 121\u2013130 (2018). DOI: 10.1182/blood-2017-07-793760"
                    },
                    {
                        "ref-fulltext": "Zhu, F., Hu, Y., Guoqing, W., Huang, H. & Wu, W. Incidence and risk factors associated with infection after chimeric antigen receptor T cell therapy for relapsed/refractory B-cell malignancies. Blood. 134(Supplement_1), 3220 (2019). DOI: 10.1182/blood-2019-129649",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Incidence and risk factors associated with infection after chimeric antigen receptor T cell therapy for relapsed/refractory B-cell malignancies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2019-129649",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089020077",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "134",
                                    "@issue": "Supplement_1"
                                },
                                "pagerange": {"@first": "3220"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhu",
                                    "ce:indexed-name": "Zhu F."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Hu",
                                    "ce:indexed-name": "Hu Y."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Guoqing",
                                    "ce:indexed-name": "Guoqing W."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Huang",
                                    "ce:indexed-name": "Huang H."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu W."
                                }
                            ]},
                            "ref-sourcetitle": "Blood."
                        },
                        "ce:source-text": "Zhu, F., Hu, Y., Guoqing, W., Huang, H. & Wu, W. Incidence and risk factors associated with infection after chimeric antigen receptor T cell therapy for relapsed/refractory B-cell malignancies. Blood. 134(Supplement_1), 3220 (2019). DOI: 10.1182/blood-2019-129649"
                    },
                    {
                        "ref-fulltext": "Park, J. H. et al. Cytokine release syndrome grade as a predictive marker for infections in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with chimeric antigen receptor T cells. Clin. Infect. Dis. 67, 533\u2013540 (2018). DOI: 10.1093/cid/ciy152",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Cytokine release syndrome grade as a predictive marker for infections in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with chimeric antigen receptor T cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/cid/ciy152",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85048016406",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "533",
                                    "@last": "540"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC1MXhtlCmtLzI",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park J.H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Infect. Dis."
                        },
                        "ce:source-text": "Park, J. H. et al. Cytokine release syndrome grade as a predictive marker for infections in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with chimeric antigen receptor T cells. Clin. Infect. Dis. 67, 533\u2013540 (2018). DOI: 10.1093/cid/ciy152"
                    },
                    {
                        "ref-fulltext": "Mikkilineni, L. et al. Infectious complications associated with CAR T-cell therapy. Blood. 134(Supplement_1), 4449 (2019). DOI: 10.1182/blood-2019-131170",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Infectious complications associated with CAR T-cell therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2019-131170",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089031927",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "134",
                                    "@issue": "Supplement_1"
                                },
                                "pagerange": {"@first": "4449"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Mikkilineni",
                                    "ce:indexed-name": "Mikkilineni L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood."
                        },
                        "ce:source-text": "Mikkilineni, L. et al. Infectious complications associated with CAR T-cell therapy. Blood. 134(Supplement_1), 4449 (2019). DOI: 10.1182/blood-2019-131170"
                    },
                    {
                        "ref-fulltext": "Syed, T. I. S. et al. Infections associated with CAR T therapy for treatment of hematological malignancies. Blood. 134(Supplement_1), 4442 (2019). DOI: 10.1182/blood-2019-127452",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Infections associated with CAR T therapy for treatment of hematological malignancies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2019-127452",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089027051",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "134",
                                    "@issue": "Supplement_1"
                                },
                                "pagerange": {"@first": "4442"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.I.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Syed",
                                    "ce:indexed-name": "Syed T.I.S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood."
                        },
                        "ce:source-text": "Syed, T. I. S. et al. Infections associated with CAR T therapy for treatment of hematological malignancies. Blood. 134(Supplement_1), 4442 (2019). DOI: 10.1182/blood-2019-127452"
                    },
                    {
                        "ref-fulltext": "Vora, S. B. et al. Infectious complications following CD19 chimeric antigen receptor t-cell therapy for children, adolescents, and young adults. Open Forum Infect. Dis. 7, ofaa121 (2020). DOI: 10.1093/ofid/ofaa121",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Infectious complications following CD19 chimeric antigen receptor t-cell therapy for children, adolescents, and young adults"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/ofid/ofaa121",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089017268",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "ofaa121"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Vora",
                                    "ce:indexed-name": "Vora S.B."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Open Forum Infect. Dis."
                        },
                        "ce:source-text": "Vora, S. B. et al. Infectious complications following CD19 chimeric antigen receptor t-cell therapy for children, adolescents, and young adults. Open Forum Infect. Dis. 7, ofaa121 (2020). DOI: 10.1093/ofid/ofaa121"
                    },
                    {
                        "ref-fulltext": "Young, J. H. et al. Infections after transplantation of bone marrow or peripheral blood stem cells from unrelated donors. Biol. Blood Marrow Transplant. 22, 359\u2013370 (2016). DOI: 10.1016/j.bbmt.2015.09.013",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Infections after transplantation of bone marrow or peripheral blood stem cells from unrelated donors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.bbmt.2015.09.013",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84958602733",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "359",
                                    "@last": "370"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Young",
                                    "ce:indexed-name": "Young J.H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biol. Blood Marrow Transplant."
                        },
                        "ce:source-text": "Young, J. H. et al. Infections after transplantation of bone marrow or peripheral blood stem cells from unrelated donors. Biol. Blood Marrow Transplant. 22, 359\u2013370 (2016). DOI: 10.1016/j.bbmt.2015.09.013"
                    },
                    {
                        "ref-fulltext": "Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf (2020).",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference:8.5x11.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85084547267",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "Common Terminology Criteria for Adverse Events (CTCAE)"
                        },
                        "ce:source-text": "Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf (2020)."
                    },
                    {
                        "ref-fulltext": "Neelapu, S. S. et al. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma. N. Engl. J. Med. 377, 2531\u20132544 (2017). DOI: 10.1056/NEJMoa1707447",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa1707447",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85040170618",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "377"},
                                "pagerange": {
                                    "@first": "2531",
                                    "@last": "2544"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC1MXhtVGjtbw%3D",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Neelapu",
                                    "ce:indexed-name": "Neelapu S.S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Neelapu, S. S. et al. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma. N. Engl. J. Med. 377, 2531\u20132544 (2017). DOI: 10.1056/NEJMoa1707447"
                    },
                    {
                        "ref-fulltext": "Schuster, S. J. et al. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N. Engl. J. Med. 380, 45\u201356 (2019). DOI: 10.1056/NEJMoa1804980",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa1804980",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85058995720",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "380"},
                                "pagerange": {
                                    "@first": "45",
                                    "@last": "56"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC1MXhtFKmtbc%3D",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Schuster",
                                    "ce:indexed-name": "Schuster S.J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Schuster, S. J. et al. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N. Engl. J. Med. 380, 45\u201356 (2019). DOI: 10.1056/NEJMoa1804980"
                    },
                    {
                        "ref-fulltext": "Abramson, J. S. et al. Pivotal safety and efficacy results from transcend NHL 001, a multicenter phase 1 study of Lisocabtagene Maraleucel (liso-cel) in relapsed/refractory (R/R) large B cell lymphomas. Blood. 134(Supplement_1), 241 (2019). DOI: 10.1182/blood-2019-127508",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Pivotal safety and efficacy results from transcend NHL 001, a multicenter phase 1 study of Lisocabtagene Maraleucel (liso-cel) in relapsed/refractory (R/R) large B cell lymphomas"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2019-127508",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079068010",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "134",
                                    "@issue": "Supplement_1"
                                },
                                "pagerange": {"@first": "241"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Abramson",
                                    "ce:indexed-name": "Abramson J.S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood."
                        },
                        "ce:source-text": "Abramson, J. S. et al. Pivotal safety and efficacy results from transcend NHL 001, a multicenter phase 1 study of Lisocabtagene Maraleucel (liso-cel) in relapsed/refractory (R/R) large B cell lymphomas. Blood. 134(Supplement_1), 241 (2019). DOI: 10.1182/blood-2019-127508"
                    },
                    {
                        "ref-fulltext": "Cordeiro, A. et al. Late events after treatment with CD19-targeted chimeric antigen receptor modified T cells. Biol. Blood Marrow Transplant. 26, 26\u201333 (2020). DOI: 10.1016/j.bbmt.2019.08.003",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Late events after treatment with CD19-targeted chimeric antigen receptor modified T cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.bbmt.2019.08.003",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85072258712",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "26",
                                    "@last": "33"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC1MXhslelsbnK",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Cordeiro",
                                    "ce:indexed-name": "Cordeiro A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biol. Blood Marrow Transplant."
                        },
                        "ce:source-text": "Cordeiro, A. et al. Late events after treatment with CD19-targeted chimeric antigen receptor modified T cells. Biol. Blood Marrow Transplant. 26, 26\u201333 (2020). DOI: 10.1016/j.bbmt.2019.08.003"
                    },
                    {
                        "ref-fulltext": "Riedell, P. A. et al. A multicenter retrospective analysis of clinical outcomes, toxicities, and patterns of use in institutions utilizing commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B-cell lymphomas. Blood. 134(Supplement_1), 1599 (2019). DOI: 10.1182/blood-2019-127490",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "A multicenter retrospective analysis of clinical outcomes, toxicities, and patterns of use in institutions utilizing commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B-cell lymphomas"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2019-127490",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079044421",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "134",
                                    "@issue": "Supplement_1"
                                },
                                "pagerange": {"@first": "1599"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "P.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Riedell",
                                    "ce:indexed-name": "Riedell P.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood."
                        },
                        "ce:source-text": "Riedell, P. A. et al. A multicenter retrospective analysis of clinical outcomes, toxicities, and patterns of use in institutions utilizing commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B-cell lymphomas. Blood. 134(Supplement_1), 1599 (2019). DOI: 10.1182/blood-2019-127490"
                    },
                    {
                        "ref-fulltext": "Haidar, G. et al. Invasive mold infections after chimeric antigen receptor-modified T-cell Therapy: a case series, review of the literature, and implications for prophylaxis. Clin. Infect. Dis. 10.1093/cid/ciz1127 (2019).",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1093/cid/ciz1127",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Invasive mold infections after chimeric antigen receptor-modified T-cell Therapy: A case series, review of the literature, and implications for prophylaxis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85088846749",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Haidar",
                                    "ce:indexed-name": "Haidar G."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Infect. Dis"
                        },
                        "ce:source-text": "Haidar, G. et al. Invasive mold infections after chimeric antigen receptor-modified T-cell Therapy: a case series, review of the literature, and implications for prophylaxis. Clin. Infect. Dis. 10.1093/cid/ciz1127 (2019)."
                    },
                    {
                        "ref-fulltext": "Mahmoudjafari, Z. et al. American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on chimeric antigen receptor T cell therapy administrative, logistic, and toxicity management practices in the United States. Biol. Blood Marrow Transplant. 25, 26\u201333 (2019). DOI: 10.1016/j.bbmt.2018.09.024",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on chimeric antigen receptor T cell therapy administrative, logistic, and toxicity management practices in the United States"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.bbmt.2018.09.024",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85055977770",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "26",
                                    "@last": "33"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Mahmoudjafari",
                                    "ce:indexed-name": "Mahmoudjafari Z."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biol. Blood Marrow Transplant."
                        },
                        "ce:source-text": "Mahmoudjafari, Z. et al. American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on chimeric antigen receptor T cell therapy administrative, logistic, and toxicity management practices in the United States. Biol. Blood Marrow Transplant. 25, 26\u201333 (2019). DOI: 10.1016/j.bbmt.2018.09.024"
                    },
                    {
                        "ref-fulltext": "Yakoub-Agha, I. et al. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Haematologica. 105, 297\u2013316 (2020). DOI: 10.3324/haematol.2019.229781",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3324/haematol.2019.229781",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85078868386",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "105"},
                                "pagerange": {
                                    "@first": "297",
                                    "@last": "316"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Yakoub-Agha",
                                    "ce:indexed-name": "Yakoub-Agha I."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haematologica."
                        },
                        "ce:source-text": "Yakoub-Agha, I. et al. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Haematologica. 105, 297\u2013316 (2020). DOI: 10.3324/haematol.2019.229781"
                    },
                    {
                        "ref-fulltext": "Bhella, S. et al. Choosing wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group\u2019s list of 5 tests and treatments to question in blood and marrow transplantation. Biol. Blood Marrow Transplant. 24, 909\u2013913 (2018). DOI: 10.1016/j.bbmt.2018.01.017",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Choosing wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group\u2019s list of 5 tests and treatments to question in blood and marrow transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.bbmt.2018.01.017",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044666234",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "909",
                                    "@last": "913"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Bhella",
                                    "ce:indexed-name": "Bhella S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biol. Blood Marrow Transplant."
                        },
                        "ce:source-text": "Bhella, S. et al. Choosing wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group\u2019s list of 5 tests and treatments to question in blood and marrow transplantation. Biol. Blood Marrow Transplant. 24, 909\u2013913 (2018). DOI: 10.1016/j.bbmt.2018.01.017"
                    },
                    {
                        "ref-fulltext": "Bhoj, V. G. et al. Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy. Blood. 128, 360\u2013370 (2016). DOI: 10.1182/blood-2016-01-694356",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2016-01-694356",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84978951469",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "128"},
                                "pagerange": {
                                    "@first": "360",
                                    "@last": "370"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC28Xhs1egsL%2FK",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "V.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Bhoj",
                                    "ce:indexed-name": "Bhoj V.G."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood."
                        },
                        "ce:source-text": "Bhoj, V. G. et al. Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy. Blood. 128, 360\u2013370 (2016). DOI: 10.1182/blood-2016-01-694356"
                    },
                    {
                        "ref-fulltext": "Hill, J. A. et al. Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy. Blood Adv. 3, 3590\u20133601 (2019). DOI: 10.1182/bloodadvances.2019000717",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/bloodadvances.2019000717",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074643408",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {
                                    "@first": "3590",
                                    "@last": "3601"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Hill",
                                    "ce:indexed-name": "Hill J.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv."
                        },
                        "ce:source-text": "Hill, J. A. et al. Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy. Blood Adv. 3, 3590\u20133601 (2019). DOI: 10.1182/bloodadvances.2019000717"
                    },
                    {
                        "ref-fulltext": "Locke, F. L. et al. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial. Lancet Oncol. 20, 31\u201342 (2019). DOI: 10.1016/S1470-2045(18)30864-7",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S1470-2045(18)30864-7",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059501669",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "31",
                                    "@last": "42"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC1cXisVSgt7bE",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "F.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Locke",
                                    "ce:indexed-name": "Locke F.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol."
                        },
                        "ce:source-text": "Locke, F. L. et al. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial. Lancet Oncol. 20, 31\u201342 (2019). DOI: 10.1016/S1470-2045(18)30864-7"
                    },
                    {
                        "ref-fulltext": "Wang, Y. et al. Kinetics of immune reconstitution after CD19 CAR-T cell therapy in ALL patients. Blood 134(Supplement_1), 1301 (2019). DOI: 10.1182/blood-2019-127808",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Kinetics of immune reconstitution after CD19 CAR-T cell therapy in ALL patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2019-127808",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089030459",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "134",
                                    "@issue": "Supplement_1"
                                },
                                "pagerange": {"@first": "1301"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang Y."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Wang, Y. et al. Kinetics of immune reconstitution after CD19 CAR-T cell therapy in ALL patients. Blood 134(Supplement_1), 1301 (2019). DOI: 10.1182/blood-2019-127808"
                    },
                    {
                        "ref-fulltext": "Luo, H. et al. Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy. J. Immunother. Cancer. 7, 271 (2019). DOI: 10.1186/s40425-019-0767-x",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s40425-019-0767-x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85073722702",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "271"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Luo",
                                    "ce:indexed-name": "Luo H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Immunother. Cancer."
                        },
                        "ce:source-text": "Luo, H. et al. Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy. J. Immunother. Cancer. 7, 271 (2019). DOI: 10.1186/s40425-019-0767-x"
                    },
                    {
                        "ref-fulltext": "Xu, X. et al. Effective treatment of severe COVID-19 patients with Tocilizumab. Proc Natl. Acad. Sci. USA 117, 10970\u201310975 (2020).",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Effective treatment of severe COVID-19 patients with Tocilizumab"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85084759230",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "117"},
                                "pagerange": {
                                    "@first": "10970",
                                    "@last": "10975"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Xu",
                                    "ce:indexed-name": "Xu X."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Proc Natl. Acad. Sci. USA"
                        },
                        "ce:source-text": "Xu, X. et al. Effective treatment of severe COVID-19 patients with Tocilizumab. Proc Natl. Acad. Sci. USA 117, 10970\u201310975 (2020)."
                    },
                    {
                        "ref-fulltext": "Tocilizumab in COVID-19 pneumonia (TOCIVID-19). https://ClinicalTrials.gov/show/NCT04317092 (2020).",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://ClinicalTrials.gov/show/NCT04317092",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85088998861",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)"
                        },
                        "ce:source-text": "Tocilizumab in COVID-19 pneumonia (TOCIVID-19). https://ClinicalTrials.gov/show/NCT04317092 (2020)."
                    },
                    {
                        "ref-fulltext": "A Study to evaluate the safety and efficacy of tocilizumab in patients with severe COVID-19 pneumonia. https://ClinicalTrials.gov/show/NCT04320615 (2020).",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://ClinicalTrials.gov/show/NCT04320615",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR29",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85087213789",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients with Severe COVID-19 Pneumonia"
                        },
                        "ce:source-text": "A Study to evaluate the safety and efficacy of tocilizumab in patients with severe COVID-19 pneumonia. https://ClinicalTrials.gov/show/NCT04320615 (2020)."
                    },
                    {
                        "ref-fulltext": "Favipiravir combined with Tocilizumab in the treatment of corona virus disease 2019. https://ClinicalTrials.gov/show/NCT04310228 (2020).",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://ClinicalTrials.gov/show/NCT04310228",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR30",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85085474673",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "Favipiravir Combined with Tocilizumab in the Treatment of Corona Virus Disease 2019"
                        },
                        "ce:source-text": "Favipiravir combined with Tocilizumab in the treatment of corona virus disease 2019. https://ClinicalTrials.gov/show/NCT04310228 (2020)."
                    },
                    {
                        "ref-fulltext": "Tocilizumab vs CRRT in management of cytokine release syndrome (CRS) in COVID-19. https://ClinicalTrials.gov/show/NCT04306705 (2020).",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://ClinicalTrials.gov/show/NCT04306705",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR31",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85088604394",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "Tocilizumab Vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19"
                        },
                        "ce:source-text": "Tocilizumab vs CRRT in management of cytokine release syndrome (CRS) in COVID-19. https://ClinicalTrials.gov/show/NCT04306705 (2020)."
                    },
                    {
                        "ref-fulltext": "Tocilizumab for SARS-CoV2 severe pneumonitis. https://ClinicalTrials.gov/show/NCT04315480 (2020).",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://ClinicalTrials.gov/show/NCT04315480",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR32",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85088941246",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "Tocilizumab for Sars-Cov2 Severe Pneumonitis"
                        },
                        "ce:source-text": "Tocilizumab for SARS-CoV2 severe pneumonitis. https://ClinicalTrials.gov/show/NCT04315480 (2020)."
                    },
                    {
                        "ref-fulltext": "Anti-il6 treatment of serious COVID-19 disease with threatening respiratory failure. https://ClinicalTrials.gov/show/NCT04322773 (2020).",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://ClinicalTrials.gov/show/NCT04322773",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR33",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85085896440",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "Anti-Il6 Treatment of Serious COVID-19 Disease with Threatening Respiratory Failure"
                        },
                        "ce:source-text": "Anti-il6 treatment of serious COVID-19 disease with threatening respiratory failure. https://ClinicalTrials.gov/show/NCT04322773 (2020)."
                    },
                    {
                        "ref-fulltext": "Zhang, X. et al. First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab. Blood Adv. 4, 1307\u20131310 (2020). DOI: 10.1182/bloodadvances.2020001907",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/bloodadvances.2020001907",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR34",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85083561828",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "1307",
                                    "@last": "1310"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang X."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv."
                        },
                        "ce:source-text": "Zhang, X. et al. First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab. Blood Adv. 4, 1307\u20131310 (2020). DOI: 10.1182/bloodadvances.2020001907"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "New York",
            "@id": "60009343",
            "affilname": "Memorial Sloan-Kettering Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "New York",
            "@id": "60007997",
            "affilname": "Weill Cornell Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Milan",
            "@id": "60006583",
            "affilname": "Fondazione IRCCS Istituto Nazionale dei Tumori, Milan",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006583",
            "affiliation-country": "Italy"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85089023617",
        "dc:description": "CD19-targeted chimeric antigen receptor (CAR) T cell therapy is an effective treatment for diffuse large B cell lymphoma (DLBCL). In addition to cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity (ICANS), B cell aplasia and hypogammaglobulinemia are common toxicities predisposing these patients to infections. We analyzed 60 patients with DLBCL treated with FDA-approved CD19 CAR T cells and report the incidence, risk factors, and management of infections during the first year after treatment. A total of 101 infectious events were observed, including 25 mild, 51 moderate, 23 severe, 1 life-threatening, and 1 fatal infection. Bacteria were the most common causative pathogens. The cumulative incidence of overall, bacterial, severe bacterial, viral, and fungal infection at 1 year were 63.3%, 57.2%, 29.6%, 44.7%, and 4%, respectively. In multivariate analyses, the use of systemic corticosteroids for the management of CRS or ICANS was associated with an increased risk of infections and prolonged admission. Impaired performance status and history of infections within 30 days before CAR T cell therapy was a risk factor for severe bacterial infection. In conclusion, infections were common within the first 60 days after CAR T cell therapy, however, they were not associated with an increased risk of death.",
        "pubmed-id": "32759935",
        "prism:coverDate": "2020-08-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85089023617",
        "dc:creator": {"author": [{
            "ce:given-name": "Kitsada",
            "preferred-name": {
                "ce:given-name": "Kitsada",
                "ce:initials": "K.",
                "ce:surname": "Wudhikarn",
                "ce:indexed-name": "Wudhikarn K."
            },
            "@seq": "1",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Wudhikarn",
            "@auid": "37091810400",
            "author-url": "https://api.elsevier.com/content/author/author_id/37091810400",
            "ce:indexed-name": "Wudhikarn K."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85089023617"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089023617&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85089023617&origin=inward"
            }
        ],
        "source-id": "21100205926",
        "citedby-count": "109",
        "prism:volume": "10",
        "subtype": "ar",
        "dc:title": "Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma",
        "openaccess": "1",
        "prism:issn": "20445385",
        "publishercopyright": "© 2020, The Author(s).",
        "article-number": "79",
        "prism:issueIdentifier": "8",
        "subtypeDescription": "Article",
        "prism:publicationName": "Blood Cancer Journal",
        "openaccessFlag": "true",
        "prism:doi": "10.1038/s41408-020-00346-7",
        "dc:identifier": "SCOPUS_ID:85089023617",
        "dc:publisher": "Springer Nature"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged, 80 and over",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Anti-Infective Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antigens, CD19",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Immunotherapy, Adoptive",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Incidence",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Infections",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Lymphoma, Large B-Cell, Diffuse",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Risk Factors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Treatment Outcome",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Young Adult",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Kitsada",
            "preferred-name": {
                "ce:given-name": "Kitsada",
                "ce:initials": "K.",
                "ce:surname": "Wudhikarn",
                "ce:indexed-name": "Wudhikarn K."
            },
            "@seq": "1",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Wudhikarn",
            "@auid": "37091810400",
            "author-url": "https://api.elsevier.com/content/author/author_id/37091810400",
            "ce:indexed-name": "Wudhikarn K."
        },
        {
            "ce:given-name": "M. Lia",
            "preferred-name": {
                "ce:given-name": "M. Lia",
                "ce:initials": "M.L.",
                "ce:surname": "Palomba",
                "ce:indexed-name": "Palomba M.L."
            },
            "@seq": "2",
            "ce:initials": "M.L.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                }
            ],
            "ce:surname": "Palomba",
            "@auid": "7004154707",
            "author-url": "https://api.elsevier.com/content/author/author_id/7004154707",
            "ce:indexed-name": "Palomba M.L."
        },
        {
            "ce:given-name": "Martina",
            "preferred-name": {
                "ce:given-name": "Martina",
                "ce:initials": "M.",
                "ce:surname": "Pennisi",
                "ce:indexed-name": "Pennisi M."
            },
            "@seq": "3",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60006583",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006583"
                }
            ],
            "ce:surname": "Pennisi",
            "@auid": "56325972600",
            "author-url": "https://api.elsevier.com/content/author/author_id/56325972600",
            "ce:indexed-name": "Pennisi M."
        },
        {
            "ce:given-name": "Marta",
            "preferred-name": {
                "ce:given-name": "Marta",
                "ce:initials": "M.",
                "ce:surname": "Garcia-Recio",
                "ce:indexed-name": "Garcia-Recio M."
            },
            "@seq": "4",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009343",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
            },
            "ce:surname": "Garcia-Recio",
            "@auid": "57189461287",
            "author-url": "https://api.elsevier.com/content/author/author_id/57189461287",
            "ce:indexed-name": "Garcia-Recio M."
        },
        {
            "ce:given-name": "Jessica R.",
            "preferred-name": {
                "ce:given-name": "Jessica R.",
                "ce:initials": "J.R.",
                "ce:surname": "Flynn",
                "ce:indexed-name": "Flynn J.R."
            },
            "@seq": "5",
            "ce:initials": "J.R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009343",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
            },
            "ce:surname": "Flynn",
            "@auid": "57203165820",
            "author-url": "https://api.elsevier.com/content/author/author_id/57203165820",
            "ce:indexed-name": "Flynn J.R."
        },
        {
            "ce:given-name": "Sean M.",
            "preferred-name": {
                "ce:given-name": "Sean M.",
                "ce:initials": "S.M.",
                "ce:surname": "Devlin",
                "ce:indexed-name": "Devlin S.M."
            },
            "@seq": "6",
            "ce:initials": "S.M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009343",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
            },
            "ce:surname": "Devlin",
            "@auid": "55515156100",
            "author-url": "https://api.elsevier.com/content/author/author_id/55515156100",
            "ce:indexed-name": "Devlin S.M."
        },
        {
            "ce:given-name": "Aishat",
            "preferred-name": {
                "ce:given-name": "Aishat",
                "ce:initials": "A.",
                "ce:surname": "Afuye",
                "ce:indexed-name": "Afuye A."
            },
            "@seq": "7",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009343",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
            },
            "ce:surname": "Afuye",
            "@auid": "57218200707",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218200707",
            "ce:indexed-name": "Afuye A."
        },
        {
            "ce:given-name": "Mari Lynne",
            "preferred-name": {
                "ce:given-name": "Mari Lynne",
                "ce:initials": "M.L.",
                "ce:surname": "Silverberg",
                "ce:indexed-name": "Silverberg M.L."
            },
            "@seq": "8",
            "ce:initials": "M.L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009343",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
            },
            "ce:surname": "Silverberg",
            "@auid": "57215874261",
            "author-url": "https://api.elsevier.com/content/author/author_id/57215874261",
            "ce:indexed-name": "Silverberg M.L."
        },
        {
            "ce:given-name": "Molly A.",
            "preferred-name": {
                "ce:given-name": "Molly A.",
                "ce:initials": "M.A.",
                "ce:surname": "Maloy",
                "ce:indexed-name": "Maloy M.A."
            },
            "@seq": "9",
            "ce:initials": "M.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009343",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
            },
            "ce:surname": "Maloy",
            "@auid": "55711016700",
            "author-url": "https://api.elsevier.com/content/author/author_id/55711016700",
            "ce:indexed-name": "Maloy M.A."
        },
        {
            "ce:given-name": "Gunjan L.",
            "preferred-name": {
                "ce:given-name": "Gunjan L.",
                "ce:initials": "G.L.",
                "ce:surname": "Shah",
                "ce:indexed-name": "Shah G.L."
            },
            "@seq": "10",
            "ce:initials": "G.L.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                }
            ],
            "ce:surname": "Shah",
            "@auid": "55628590808",
            "author-url": "https://api.elsevier.com/content/author/author_id/55628590808",
            "ce:indexed-name": "Shah G.L."
        },
        {
            "ce:given-name": "Michael",
            "preferred-name": {
                "ce:given-name": "Michael",
                "ce:initials": "M.",
                "ce:surname": "Scordo",
                "ce:indexed-name": "Scordo M."
            },
            "@seq": "11",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                }
            ],
            "ce:surname": "Scordo",
            "@auid": "36193395200",
            "author-url": "https://api.elsevier.com/content/author/author_id/36193395200",
            "ce:indexed-name": "Scordo M."
        },
        {
            "ce:given-name": "Parastoo B.",
            "preferred-name": {
                "ce:given-name": "Parastoo B.",
                "ce:initials": "P.B.",
                "ce:surname": "Dahi",
                "ce:indexed-name": "Dahi P.B."
            },
            "@seq": "12",
            "ce:initials": "P.B.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                }
            ],
            "ce:surname": "Dahi",
            "@auid": "56015514000",
            "author-url": "https://api.elsevier.com/content/author/author_id/56015514000",
            "ce:indexed-name": "Dahi P.B."
        },
        {
            "ce:given-name": "Craig S.",
            "preferred-name": {
                "ce:given-name": "Craig S.",
                "ce:initials": "C.S.",
                "ce:surname": "Sauter",
                "ce:indexed-name": "Sauter C.S."
            },
            "@seq": "13",
            "ce:initials": "C.S.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                }
            ],
            "ce:surname": "Sauter",
            "@auid": "25028670000",
            "author-url": "https://api.elsevier.com/content/author/author_id/25028670000",
            "ce:indexed-name": "Sauter C.S."
        },
        {
            "ce:given-name": "Connie L.",
            "preferred-name": {
                "ce:given-name": "Connie L.",
                "ce:initials": "C.L.",
                "ce:surname": "Batlevi",
                "ce:indexed-name": "Batlevi C.L."
            },
            "@seq": "14",
            "ce:initials": "C.L.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                }
            ],
            "ce:surname": "Batlevi",
            "@auid": "56131589300",
            "author-url": "https://api.elsevier.com/content/author/author_id/56131589300",
            "ce:indexed-name": "Batlevi C.L."
        },
        {
            "ce:given-name": "Bianca D.",
            "preferred-name": {
                "ce:given-name": "Bianca D.",
                "ce:initials": "B.D.",
                "ce:surname": "Santomasso",
                "ce:indexed-name": "Santomasso B.D."
            },
            "@seq": "15",
            "ce:initials": "B.D.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                },
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                }
            ],
            "ce:surname": "Santomasso",
            "@auid": "23104363800",
            "author-url": "https://api.elsevier.com/content/author/author_id/23104363800",
            "ce:indexed-name": "Santomasso B.D."
        },
        {
            "ce:given-name": "Elena",
            "preferred-name": {
                "ce:given-name": "Elena",
                "ce:initials": "E.",
                "ce:surname": "Mead",
                "ce:indexed-name": "Mead E."
            },
            "@seq": "16",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                },
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                }
            ],
            "ce:surname": "Mead",
            "@auid": "57189727938",
            "author-url": "https://api.elsevier.com/content/author/author_id/57189727938",
            "ce:indexed-name": "Mead E."
        },
        {
            "ce:given-name": "Susan K.",
            "preferred-name": {
                "ce:given-name": "Susan K.",
                "ce:initials": "S.K.",
                "ce:surname": "Seo",
                "ce:indexed-name": "Seo S.K."
            },
            "@seq": "17",
            "ce:initials": "S.K.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                },
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                }
            ],
            "ce:surname": "Seo",
            "@auid": "7202469856",
            "author-url": "https://api.elsevier.com/content/author/author_id/7202469856",
            "ce:indexed-name": "Seo S.K."
        },
        {
            "ce:given-name": "Miguel-Angel",
            "preferred-name": {
                "ce:given-name": "Miguel Angel",
                "ce:initials": "M.A.",
                "ce:surname": "Perales",
                "ce:indexed-name": "Perales M.A."
            },
            "@seq": "18",
            "ce:initials": "M.-A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                }
            ],
            "ce:surname": "Perales",
            "@auid": "6701893624",
            "author-url": "https://api.elsevier.com/content/author/author_id/6701893624",
            "ce:indexed-name": "Perales M.-A."
        }
    ]}
}}